Tenapanor Improves Long-term Control of Hyperphosphatemia in Patients Receiving Maintenance Dialysis: the NORMALIZE Study.
Arnold L SilvaGlenn M ChertowGermán T HernándezRobert I LynnDavid P TietjenDavid P RosenbaumYang YangSusan EdelsteinPublished in: Kidney360 (2023)
A Long-Term Study to Evaluate the Ability of Tenapanor Alone or in Combination With Sevelamer to Treat to Goal Serum Phosphorus in Patients With End-Stage Kidney Disease on Dialysis (NORMALIZE), NCT03988920.